Blockade of the nociceptin/orphanin FQ/NOP receptor system in the rat ventrolateral periaqueductal gray potentiates DAMGO analgesia

Peptides

Volumn 28, Issue 7, 2007, Pages 1441-1446

  Scoto, Giovanna M ^a   Aricò, Giuseppina ^a   Ronsisvalle, Simone ^a   Parenti, Carmela ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

DAMGO; N OFQ; Pain; UFP 101; vlPAG

Indexed keywords

ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; NOCICEPTIN; NOCICEPTIN RECEPTOR; NOCICEPTIN RECEPTOR AGONIST; NOCICEPTIN RECEPTOR ANTAGONIST; UFP 101; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG POTENTIATION; MALE; NONHUMAN; PAIN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; TAIL FLICK TEST;

ANALGESICS, OPIOID; ANIMALS; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; MALE; OPIOID PEPTIDES; PAIN MEASUREMENT; PERIAQUEDUCTAL GRAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID;

RATTUS;

EID: 34447619137     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2007.05.013     Document Type: Article

References (44)

1. Anton B., Fein J., To T., Li X., Silberstein L., and Evans C.J. Immunohistochemical localization of ORL-1 in the central nervous system of the rat. J Comp Neurol 368 2 (1996) 229-251
2. Basbaum A.I., and Fields H.L. Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci 7 (1984) 309-338
3. Behbehani M.M. Functional characteristics of the midbrain periaqueductal gray. Prog Neurobiol 46 6 (1995) 575-605
4. Bodnar R.J., Williams C.L., Lee S.J., and Pasternak G.W. Role of mu 1-opiate receptors in supraspinal opiate analgesia: a microinjection study. Brain Res 447 (1988) 25-34
5. 15] nociceptin/orphanin FQ, a highly potent agonist of the NOP receptor, on in vitro and in vivo gastrointestinal functions. Peptides 26 (2005) 1590-1597
6. Bytner B., Huang Y.H., Yu L.C., Lundeberg T., Nylander I., and Rosen A. Nociceptin/orphanin FQ into the rat periaqueductal gray decreases the withdrawal latency to heat and loading, an effect reversed by (Nphe(1))nociceptin(1-13)NH(2). Brain Res 922 1 (2001) 118-124
7. 2, a novel potent and selective antagonist of the nociceptin/orfanin FQ receptor. Br. J. Pharmacol 136 (2002) 303-311
8. Calò G., Guerrini R., Rizzi A., Salvatori S., Burmeister M., Kapusta D.R., et al. UFP-101, a Peptide Antagonist Selective for the nociceptin/orphanin FQ Receptor. CNS Drug Reviews 11 2 (2005) 97-112
9. Chen X., Geller B., and Adler M.W. Nociceptin/orphanin FQ blocks the antinociception induced by mu, kappa and delta opioid agonists on the cold water tail-flick test. Eur J of Pharmacol 557 (2007) 32-36
10. 2 is a competitive antagonist of NOP receptor in the periaqueductal gray. Eur J Pharmacol 515 (2005) 47-53
11. Chiou L.C., Chuang K.C., Wichmann J., and Adam G. Ro 64-6198 [(1S,3aS)-8-(2,3,3a,4,5,6-hexahydro-1H-phenalen-1-yl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one] acts differently from nociceptin/orphanin FQ in rat periaqueductal gray slices. J Pharmacol Exp Ther 311 2 (2004) 645-651
12. Chiou L.C., Fan S.H., Chuang K.C., Liao Y.Y., and Lee S.Z. Pharmacological characterization of nociceptin/orphanin FQ receptors, a novel opioid receptor family, in the midbrain periaqueductal gray. Ann NY Acad Sci 1025 (2004) 398-403
13. Economidou D., Policani F., Angellotti T., Massi M., Terada T., and Ciccocioppo R. Effect of novel NOP receptor ligands on food intake in rats. Peptides 27 (2006) 775-783
14. Grisel J.E., Mogil J.S., Belknap J.K., and Grandy D.K. Orphanin FQ acts as a supraspinal, but not a spinal, anti-opioid peptide. Neuroreport 7 13 (1996) 2125-2129
15. Grisel J.E., and Mogil J.S. Effects of supraspinal orphanin FQ/nociceptin. Peptides 21 (2000) 1037-1045
16. Hashiba E., Hirota K., Kudo T., Calo G., Guerrini R., and Matsuki A. Effects of nociceptin/orphanin FQ receptor ligands on blood pressure, heart rate, and plasma catecholamine concentrations in guinea pigs. Naunyn Schmiedebergs Arch Pharmacol 367 (2003) 342-347
17. Heinricher M.M. Orphanin FQ/nociceptin: from neural circuitry to behaviour. Life Sci. 73 (2003) 813-822
18. Houtani T., Nishi M., Takeshima H., Nukada T., and Sugimoto T. Structure and regional distribution of nociceptin/orphanin FQ precursor. Biochem Biophys Res Commun 219 3 (1996) 714-719
19. Jensen T.S., and Yaksh T.L. Comparison of the antinociceptive action of mu and delta opioid receptor ligands in the periaqueductal gray matter, medial and paramedial ventral medulla in the rat as studied by the microinjection technique. Brain Res 372 2 (1986) 301-312
20. Krowicki Z.K., and Kapusta D.R. Tonic nociceptinergic inputs to neurons in the hypothalamic paraventricular nucleus contribute to the sympathetic vasomotor tone and water and electrolyte homeostasis in conscious rats. J Pharmacol Exp Ther 317 (2006) 446-453
21. Kuzmin A., Sandin J., Terenius L., and Ogren S.O. Evidence in locomotion test fort he functional heterogeneity of ORL-1 receptors. Br J Pharmacol 141 (2004) 132-140
22. Lachowicz J.E., Shen Y., Monsma Jr. F.J., and Sibley D.R. Molecular cloning of a novel G protein-coupled receptor related to the opiate receptor family. J Neuuochem 64 1 (1995) 34-40
23. Mansour A., Khachaturian H., Lewis M.E., Akil H., and Watson S.J. Autoradiographic differentiation of mu, delta and kappa opioid receptors in the rat forebrain and midbrain. J Neurosci 7 (1987) 2445-2464
24. Mason P. Central mechanism of pain modulation. Curr Opin Neurobiol 9 (1999) 436-441
25. 1 receptor. Nature 377 (1995) 532-535
26. Mogil J.S., Grisel J.E., Reinscheid R.K., Civelli O., Belknap J.K., and Grandy D.K. Orphanin FQ is a functional anti-opioid peptide. Neuroscience 75 2 (1996) 333-337
27. Mogil J.S., Grisel J.E., Zhangs G., Belknap J.K., and Grandy D.K. Functional antagonism of μ-, δ- and κ-opioid antinociception by orphanin FQ. Neurosci Lett 214 (1996) 131-134
28. Mogil J.S., and Pasternak G.W. The molecular and behavioural pharmacology of the orphanin FQ/nociceptin peptide and receptor family. Pharmacol Rev 53 (2001) 381-415
29. Morgan M.M., Griesel J.E., Robbins C.S., and Grandy D.K. Antinociception mediated by the periaqueductal gray is attenuated by orphanin FQ. Neuroreport 8 (1997) 3431-3434
30. Nazzaro C., Rizzi A., Salvadori S., Guerrini R., Regoli D., Zeilhofer H.U., et al. UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ: behavioral and electrophysiological studies in mice. Peptides 28 (2007) 663-669
31. Nothacker H.P., Reinscheid R.K., Mansour A., Henningsen R.A., Ardati A., Monsma Jr. F.J., et al. Primary structure and tissue distribution of the orphanin FQ precursor. Proc Natl Acad Sci USA 93 (1996) 8677-8682
32. Odeh F., Antal M., and Zagal A. Heterogeneous synaptic inputs from the ventrolateral periaqueductal gray matter to neurons responding to somatosensory stimuli in the rostral ventromedial medulla of rats. Brain Res 959 2 (2003) 287-294
33. Paxinos G., and Watson C. The rat brain stereotaxic coordinates (1997), Academic Press, New York
34. Reinscheid R.K., Nothacker H.P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., et al. Orphanin FQ: a neuropeptide that activates an opioid like G protein-coupled receptor. Science 270 5237 (1995) 792-794
35. 2, potentiates morphine analgesia. Neuroreport 11 (2000) 2369-2372
36. Rossi G.C., Pasternak G.W., and Bodnar R.J. Mu and delta opioid synergy between the periaqueductal gray and the rostroventral medulla. Brain Res 665 1 (1994) 85-93
37. Scoto G.M., Santangelo N., and Parenti C. Effect of supraspinal nocistatin on nociceptin/orphanin FQ antagonism of selective opioid analgesia. Neurosci Lett 387 3 (2005) 126-129
38. Tian J.H., Xu W., Zhang W., Fang Y., Grisel J.E., Mogil J.S., et al. Involvement of endogenous orphanin FQ in electroacupuncture-induced analgesia. Neuroreport 8 2 (1997) 497-500
39. 1 receptor ligand nociceptin on membrane properties of the rat periaqueductal gray neurons in vitro. J Neurosci 17 3 (1997) 996-1003
40. Vitale G., Arletti R., Ruggieri V., Cifani C., and Massi M. Anxiolytic-like effects of nociceptin/orphanin FQ in the elevated plus maze and in the conditioned defensive burying test in rats. Peptides 27 (2006) 2193-2200
41. Wang H., and Wessendorf M.W. μ- and δ-Opioid receptor mRNAs are expressed in periaqueductal gray neurons projecting to the rostral ventromedial medulla. Neuroscience 109 (2002) 619-634
42. Wang H., Zhu C.B., Cao X.D., and Wu G.C. Effect of orphanin FQ on acupuncture analgesia and noxious stimulation in the periaqueductal gray. Sheng Li Xue Bao 50 3 (1998) 263-267
43. Yang Z.L., Zhang Y.Q., and Wu G.C. Effects of microinjection of OFQ into PAG on spinal dorsal horn WDR neurons in rats. Brain Res 888 (2001) 167-171
44. Yuan L., Han A., Chang J.K., and Han J.S. Accelerated release and production of orphanin FQ in brain of chronic morphine tolerant rats. Brain Res 826 (1999) 330-334